Opus Medical Therapies Honored with Most Fundable Company Award by Pepperdine Graziadio Business School

Atlanta, GA - September 29, 2023 - Opus Medical Therapies, a pioneering medical technology company specializing in the development of innovative cardiac interventions, is thrilled to announce that it has been recognized as one of the finalists in the Most Fundable Companies competition held by Pepperdine Graziadio Business School. Out of over 3,000 early-stage companies that vied for this prestigious award, Opus Medical Therapies stood out as one of the 17 outstanding winners.

The Most Fundable Companies program, hosted by Pepperdine Graziadio Business School, is an esteemed national competition designed to identify and celebrate high-potential startups with groundbreaking technologies, visionary leadership, and exceptional growth prospects. This recognition underscores Opus Medical Therapies' commitment to revolutionizing cardiac care with its groundbreaking transseptal transcatheter mitral valve replacement (TMVR) device and proprietary anchoring platform.

"Opus Medical Therapies' TMVR device represents a significant leap forward in the treatment of mitral valve disease, a condition that affects millions of individuals worldwide. The company's innovative solution promises to enhance patient outcomes, reduce procedure complexity, and minimize recovery times," said Dr. Vivek Rajagopal, CMO and Founder of Opus Medical Therapies.

"Recognition as a Most Fundable Company from Pepperdine Graziadio Business School is a tremendous honor and a testament to the dedication and expertise of our entire team at Opus Medical Therapies," said Jaime Sarabia, CEO at Opus Medical Therapies. "Our mission is to provide innovative and effective solutions for patients suffering from heart valve disease. This recognition reinforces our belief that we are on the right path to making a profound impact in the structural heart field."

Opus Medical Therapies' selection as a Most Fundable Company of 2023 underscores its potential to attract investment and fuel further innovation in the field of cardiac interventions. The company is already making strides in securing partnerships and funding to accelerate the development and commercialization of its groundbreaking TMVR device.

Opus Medical Therapies
5700 Highlands Parkway SE, Suite 200
Smyrna, GA 30082

Jaime Sarabia, CEO
jaime@opus-medical.com

About Opus Medical Therapies:
Opus Medical Therapies, based in Atlanta, GA, is a pioneering medical technology company dedicated to advancing cardiac care through innovative interventions. The company's focus on transseptal transcatheter mitral valve replacement (TMVR) and its proprietary anchoring platform exemplify its commitment to delivering groundbreaking solutions that improve patient outcomes and quality of life. For more information, please visit www.opus-medical.com.

About Pepperdine Most Fundable Companies
The Most Fundable Companies List is an annual program hosted by the Pepperdine Graziadio Business School aimed to promote startup business development by providing pathways for startup funding and inspiring entrepreneurial spirit across the nation. More than 3,000 companies across all 50 states applied for the 2023 program. The Pepperdine Graziadio Business School's Most Fundable Companies Showcase presented by the Singleton Foundation for Financial Literacy and Entrepreneurship took place on September 28, 2023 at Pepperdine University's Villa Graziadio Executive Center.

The Most Fundable Companies program was launched by the Pepperdine Graziadio Business School in 2018 as a free resource to help entrepreneurs assess their readiness for private investment. The initiative involves a multi-phase assessment that evaluates several company variables, including financial projections, market opportunity, intellectual property, and the strength of the management team, all of which are used to generate objective and customized feedback and scoring to improve readiness for funding.

Disclaimers: The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It does not constitute investment advice, nor is it an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.

This release was published on openPR.